As Merck, AstraZeneca and other drugmakers sign on, Medicare price negotiations face critical moment By: MarketWatch September 29, 2023 at 10:20 AM EDT A deadline looms to sign drug-price negotiation agreements as industry watches for legal reprieve. Read More >> Related Stocks: AbbVie Amgen Astrazeneca Plc ADR Bristol-Myers Squibb Johnson & Johnson Merck & Co Novo Nordisk A/S ADR
